Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.43
Delayed Data
As of Sep 23
 +0.08 / +2.39%
Today’s Change
2.58
Today|||52-Week Range
5.54
-3.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues123.1M178.1M101.3M21.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses8.5M12.5M9.8M7.0M
 
 
 
 
 
Total Operating Expenses8.5M12.5M9.8M7.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income114.7M165.5M91.5M14.1M
 
 
 
 
 
Extraordinary Credit0.006.5M0.000.00
 
 
Extraordinary Charge0.00-4.0M---3.0M
 
 
 
Interest Expense On Debt5.9M5.3M4.6M4.5M
 
 
 
 
 
Other Expenses1.6M74.0K1.9M129.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income110.4M162.7M88.8M6.8M
 
 
 
 
 
Income Taxes-40.9M-62.1M-33.0M-2.7M
 
 
 
 
 
Net Income69.5M100.6M55.9M4.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS163.6M163.6M163.7M163.8M
 
 
 
 
 
Shares To Calculate EPS Diluted163.7M163.8M163.8M164.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.42$0.61$0.34$0.03
 
 
 
 
 
EPS Diluted$0.42$0.61$0.34$0.03